FocusAutism Spectrum Disorder

Tinkering with the vasopressin pathway in autism

See allHide authors and affiliations

Science Translational Medicine  08 May 2019:
Vol. 11, Issue 491, eaax7315
DOI: 10.1126/scitranslmed.aax7315

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Two clinical trials targeting the vasopressin pathway in autism highlight continuing challenges in outcome measures and statistical power.

View Full Text